Business Standard

Thursday, December 19, 2024 | 11:52 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Covid-19 vaccine Covaxin's shelf life extended to 12 months: Bharat Biotech

The multi-dose vial policy saves money for procurement agencies by reducing the cold chain logistics

Covaxin has started trials on children; it would be for children who are two years or older
Premium

Sohini Das
Bharat Biotech on Monday said that its Covid-19 vaccine Covaxin now had a shelf life of 12 months from the date of manufacture after the Central Drugs Standard Control Organisation (CDSCO) recently approved the extension.

“This approval of shelf-life extension is based on the availability of additional stability data, which was submitted to CDSCO. With the shelf-life extension, hospitals can now utilise the stock, which was nearing the expiry and avoid vaccine wastage,” the company said.

Moreover, an opened vial of Covaxin can be stored at 2-8 degree Celsius for up to 28 days and is not required to be discarded immediately

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in